M. Tamm (Basel, Switzerland), A. Hill (Edinburgh, United Kingdom), A. Singanayagam (London, United Kingdom), J. Mizgerd (Boston, United States of America)
Frequency of multidrug resistant pathogens in healthcare associated pneumonia
T. Shahzad, J. A. Khan, M. Irfan (Karachi, Pakistan)
|  |
Clinicians demonstrate substantial uncertainty in antibiotic management of HCAP and CAP with immunosuppression- a survey study
K. Brown, J. Chalmers (Dundee, United Kingdom)
|  |
Bronchiectasis: Bacteriological profile
R. G. Bopaka, H. Janah, W. El Khattabi, B. El Bied, H. Sellal, H. Afif, A. Aichane (Casablanca, Morocco)
| |
Bacterial colonization in patients with bronchiectasis
D. Coutinho, M. J. Oliveira, D. Vaz, M. Dias, M. D. C. Brito (Vila Nova de Gaia, Portugal)
| |
Pathogen profile of lung infections in systemic autoimmune diseases
B. Odler, N. Perlényi, K. Vincze, N. Eszes, Z. Kováts, A. Bohács, V. Müller (Budapest, Hungary)
| |
Impact of diabetes mellitus on inflammatory markers and severity scales in community-acquired pneumonia
J. Costa, J. Almeida, A. Marques (Gaia, Portugal)
| |
A possible association between breast cancer, bronchiectasis and nontuberculous mycobacterial (NTM) lung disease
J. Philley, C. Guthrie, S. Whitehead, A. Cook, J. Benwill, B. Brown-Elliott, S. Obayangban, L. Wyatt, R. Flores, P. Ramirez, R. McClendon, T. Drake, V. Wilhite, A. Murphy, R. Wallace, D. Griffith (Tyler, United States Of America)
| |
Management of parapneumonic effusion - Does the size of the chest drain matter?
S. Sharma, J. Kuah, A. Liju (London, United Kingdom)
| |
Bacterial and viral microbiomes in COPD exacerbations of unidentified cause
M. Garcia-Nuñez, V. Perez-Brocal, X. Pomares, M. Espasa, L. Millares, M. Gallego, R. Ferrari, S. Capilla, C. Monton, A. Moya, E. Monso (Sabadell, Valencia, Spain)
| |
Usefulness of BAL in non-HIV inmunocompromised hosts with lung infiltrates
A. Raimondi, I. Bledel, V. Patricia, B. Roxana, D. Mariano, C. M. Luna, G. Romina (Buenos Aires, Argentina)
| |
Etiological structure from sputum of patients with exacerbation of COPD
N. Bisenova, A. Yergalieva (Astana, Kazakhstan)
| |
Diagnostic accuracy of inflammatory biomarkers in bronchoalveolar lavage from patients with ventilator-associated pneumonia
N. Affara, A. Refaat, T. Hussein, W. Abdelfatah, M. Elberbi (Zagazig, Egypt)
| |
Parachlamydia acanthamoebae as a respiratory pathogen: Challenge dose titration in a bovine model
M. Lohr, A. Prohl, C. Ostermann, W. Schroedl, E. Liebler-Tenorio, G. Greub, P. Reinhold (Jena, Leipzig, Germany; Lausanne, Switzerland)
| |
Nontuberculous mycobacterial disease of the lungs in North-West region of Russia
V. Zhuravlev, T. Otten, N. Melnikova, L. Archakova, P. Gavrilov, M. Shulgina (St. Petersburg, Russian Federation)
| |
Effects of prophylactic clarithromycin administration on quality of life in non-CF bronchiectasis patients
E. Fouka, S. Anevlavis, K. Kaltsas, A. Antoniadis, D. Bouros (Thessaloniki, Alexandroupolis, Serres, Greece)
| |
A staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice
I. Inoshima, J. Bubeck Wardenburg, N. Inoshima, G. Wilke, M. Powers, K. Frank, H. Mikumo, Y. Mizuta, Y. Nakanishi (Fukuoka, Japan; Chicago, United States Of America)
| |
Occurrence of nontuberculous mycobacteria in Siberian regions
O. Alkhovik, M. Dymova, L. Evdokimova (Novosibirsk, Russian Federation)
| |
COPD and pseudomonas aeruginosa, an association
T. Alonso, R. M. Gómez-Punter, E. Vázquez, C. López, E. García, R. M. Girón, J. Ancochea (Madrid, Spain)
| |
PICTURE: Clinical pattern and pneumococcal infections in patients with community-acquired pneumonia (CAP) admitted to emergency department
F. Blasi, S. Aliberti, M. Mantero, M. Moriondo, F. Nieddu, C. Azzari (Milan, Florence, Italy)
| |